AUTH/2344/8/10 - Anonymous v Sanofi-Aventis

Conduct of representative

  • Received
    10 August 2010
  • Case number
    AUTH/2344/8/10
  • Applicable Code year
    2008
  • Completed
    23 September 2010
  • Breach Clause(s)
    15.2
  • Sanctions applied
    Undertaking received
  • Additional sanctions
  • Appeal
    No appeal
  • Review
    November 2010

Case Summary

An anonymous complainant alleged that a Sanofi-Aventis representative had held an inappropriate discussion with a consultant in the cardiology reception area. The complainant explained that the representative had, inter alia, discussed Clexane (enoxaparin) and 'asked' if the consultant would sign a character witness statement in order to obtain a shotgun licence. The complainant stated that such a request, while discussing a product, was entirely inappropriate.

The consultant was, according to the complainant, not an appropriate person to sign the representative's shotgun licence. The complainant was not aware that it was within the guidelines for the consultant to sign such a document given his professional relationship and lack of knowledge of the representative's medical history.

The detailed submission from Sanofi-Aventis is given below.

The Panel noted that according to Sanofi-Aventis the representative had made an appointment to see a doctor with the only objective of asking that doctor to sign Section D of a shotgun licence renewal form. The purpose of the meeting was made clear in advance. The representative had been waiting to see the doctor with whom he had the appointment when another doctor, whom he had known for some time, had started to talk to him. At the request of the representative that doctor had ended up signing the form and afterwards had asked questions about Sanofi-Aventis products. The representative had answered questions about one product and arranged for a colleague to call and answer another. The representative had recorded the call as a 'spec call, share exp with Rx Multaq' and the method of access as 'Rep Request'.

The Panel acknowledged that representatives would inevitably build close relationships with those upon whom they called, particularly those they had known for some years. It was, however, important that such relationships were kept on a professional basis. The Panel queried whether it was acceptable for a representative, in the course of his duty as such, ever to ask someone upon whom he called to do something for him of a private or personal nature. Clear distinctions should be made between personal and business arrangements. Representatives should be aware of the impression created by their conduct.

The Panel considered that the course of events was subject to the Code and was concerned about the impression given by the interaction which tookplace in the reception area. There were differences between the parties' accounts. However both agreed that the form had been signed and Sanofi-Aventis products had been discussed.

The Panel considered that the representative had not maintained a high standard of ethical conduct in relation to his meeting with the doctor. The Panel queried whether it was ever acceptable for a representative to ask a health professional to sign such a form. It was certainly not acceptable to do so when the meeting had not been pre-arranged, took place in a public area and formed part of a promotional call. A breach of the Code was ruled.